Physician

Thomas David Burgess, D.O.

According to 2025 Medicare claims, Thomas Burgess, D.O. (NPI: 1598296931) practices pain management in the Victoria, TX market, with the plurality of this provider's patient population coming from Victoria, TX. This provider's primary affiliated billing organization is GREATER HOUSTON INTERVENTIONAL PAIN ASSOCIATES (NPI: 1205881463; TIN: 202341026) and primary practice location at 77901-3339. Burgess is affiliated with the Main Street Rural Health Hickory ACO LLC (ACO ID: A5334) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Burgess' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 409 traditional Medicare patients, billed 5,403 HCPCS/CPT codes, and received $270,101 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,784 prescription claims across 870 beneficiaries totaling $346,082 in drug costs, led by Xtampza Er (Oxycodone Myristate). Open Payments data shows 147 records totaling $8,486. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $743 to $346,082. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$135K$270K2022 Medicare payment: $17,220 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $121,069 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $270,101 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202226118$17,220
20232431,293$121,069
20244095,403$270,101

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$173K$346K2017 Drug cost: $743 (USD; Tot_Drug_Cst)2021 Drug cost: $7,412 (USD; Tot_Drug_Cst)2022 Drug cost: $17,627 (USD; Tot_Drug_Cst)2023 Drug cost: $104,973 (USD; Tot_Drug_Cst)2024 Drug cost: $346,082 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R13$743
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202187233$7,412
2022129412$17,627
20234411,292$104,973
20248704,784$346,082

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9191$122
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more272478$89
80307Testing for presence of drug, by chemistry analyzers97103$61
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg158718$1
J1100Injection, dexamethasone sodium phosphate, 1 mg72414$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Xtampza ErOxycodone Myristate1083,215$79,652
BelbucaBuprenorphine Hcl702,020$64,486
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,52142,742$28,637
FentanylFentanyl1544,475$18,152
Nucynta ErTapentadol Hcl21584$17,884

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.147$8,486Medtronic, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas David Burgess, D.O.?

Tedicare shows public-source Medicare data for Thomas David Burgess, D.O. (NPI 1598296931), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas David Burgess, D.O. have ACO affiliation data?

Thomas David Burgess, D.O. is shown with ACO affiliation data for Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Thomas David Burgess, D.O.?

Thomas David Burgess, D.O. is linked to GREATER HOUSTON INTERVENTIONAL PAIN ASSOCIATES (billing NPI 1205881463) in the available physician profile data.

Does Thomas David Burgess, D.O. have Open Payments data?

Thomas David Burgess, D.O. has 147 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.